On September 1, 2021 Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, reported that the Company will participate in the following upcoming investor conferences in September (Press release, Chemomab, SEP 1, 2021, View Source [SID1234587139]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 16th Annual BioPharma Virtual Conference
Format: Available for 1-on-1 meetings
Date: September 8-10, 2021
Registration Link
H.C. Wainwright 23rd Annual Global Investment Conference (virtual)
Format: On demand presentation and available for 1-on-1 meetings
Date: September 13-15, 2021
Registration Link
Oppenheimer Fall Healthcare Life Sciences and MedTech Summit (virtual)
Format: Live presentation webcast and available for 1-on-1 meetings
Presentation: September 22, 8:15 am ET
Webcast Link
Cantor Fitzgerald Virtual Global Healthcare Conference
Format: Fireside chat and available for 1-on-1 meetings
Fireside Chat: September 30, 11:20 am ET
Webcast Link
The presentations and archived webcasts will also be accessible in the News and Events section of the Chemomab website.